DrugDashboards

Likmez

Metronidazole Oral · METRONIDAZOLE 100 mg/mL · Suspension · Oral · Kesin Pharma Corporation

NDC 81033-0066-20 · 200 mL in 1 BOTTLE · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $2.61 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Apr 2024Nov 2025$2.61
19 price points · per ML · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$545.00
Reported to Texas DSHS · 2025 annual filing · Kesin Pharma Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$450,913
1,087 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for metronidazole (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA216755
TE code
Approval date
Sep 22, 2023
Patents / exclusivity
2 patents, 0 exclusivities
TypeNumber / codeExpires
patent11541035Oct 4, 2039
patent12257236Jan 16, 2039

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Metronidazole Oral (Suspension)

LabelerStrengthFirst seenLast seen
Kesin Pharma CorporationMETRONIDAZOLE 100 mg/mLJul 15, 2026Sep 2, 2026
Saptalis Pharmaceuticals, LLCMETRONIDAZOLE 100 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Likmez — NDC 81033-0066-20," retrieved September 3, 2026, https://drugdashboards.com/drug/81033006620.

Free to cite with attribution — see how the data is put together.